Guardant Health
GH
#3340
Rank
C$4.91 B
Marketcap
$39.79
Share price
0.07%
Change (1 day)
33.62%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -C$0.67 Billion

According to Guardant Health 's latest financial reports the company's current earnings are C$0.64 Billion. In 2023 the company made an earning of -C$0.67 Billion, an increase over its 2022 earnings that were of -C$0.91 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.67 Billion-0.79%
2023 -C$0.67 Billion-26.73%
2022 -C$0.91 Billion69.96%
2021 -C$0.54 Billion56.35%
2020 -C$0.35 Billion252.69%
2019 -C$96.98 Million-17.22%
2018 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.41 Billion-40.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$43.92 Million-93.56%๐Ÿ‡บ๐Ÿ‡ธ USA